Might be a component of some unusual ubiquitin ligase (due to its C-terminal RING domain). Probably membrane-associated, although a purely cytoplasmic protein cannot be excluded.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: A0A3S7X5B4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 79 | 81 | PF00675 | 0.515 |
CLV_PCSK_FUR_1 | 77 | 81 | PF00082 | 0.511 |
CLV_PCSK_KEX2_1 | 77 | 79 | PF00082 | 0.508 |
CLV_PCSK_SKI1_1 | 109 | 113 | PF00082 | 0.586 |
CLV_PCSK_SKI1_1 | 120 | 124 | PF00082 | 0.500 |
DOC_CYCLIN_RxL_1 | 106 | 115 | PF00134 | 0.756 |
DOC_CYCLIN_yCln2_LP_2 | 118 | 124 | PF00134 | 0.742 |
DOC_MAPK_gen_1 | 89 | 97 | PF00069 | 0.778 |
DOC_PP1_RVXF_1 | 45 | 51 | PF00149 | 0.483 |
DOC_PP4_FxxP_1 | 19 | 22 | PF00568 | 0.449 |
DOC_USP7_MATH_1 | 91 | 95 | PF00917 | 0.723 |
DOC_WW_Pin1_4 | 112 | 117 | PF00397 | 0.772 |
DOC_WW_Pin1_4 | 25 | 30 | PF00397 | 0.519 |
LIG_14-3-3_CanoR_1 | 77 | 85 | PF00244 | 0.564 |
LIG_14-3-3_CanoR_1 | 92 | 96 | PF00244 | 0.788 |
LIG_BRCT_BRCA1_1 | 15 | 19 | PF00533 | 0.465 |
LIG_FHA_1 | 139 | 145 | PF00498 | 0.664 |
LIG_FHA_1 | 38 | 44 | PF00498 | 0.575 |
LIG_GBD_Chelix_1 | 61 | 69 | PF00786 | 0.530 |
LIG_Integrin_isoDGR_2 | 129 | 131 | PF01839 | 0.522 |
LIG_LIR_Apic_2 | 16 | 22 | PF02991 | 0.466 |
LIG_LIR_Nem_3 | 160 | 164 | PF02991 | 0.567 |
LIG_LIR_Nem_3 | 28 | 33 | PF02991 | 0.474 |
LIG_LIR_Nem_3 | 71 | 76 | PF02991 | 0.365 |
LIG_PDZ_Class_2 | 173 | 178 | PF00595 | 0.740 |
LIG_REV1ctd_RIR_1 | 72 | 83 | PF16727 | 0.627 |
LIG_SH2_STAT5 | 161 | 164 | PF00017 | 0.568 |
LIG_SH2_STAT5 | 73 | 76 | PF00017 | 0.501 |
LIG_SH3_3 | 100 | 106 | PF00018 | 0.702 |
LIG_SH3_3 | 118 | 124 | PF00018 | 0.747 |
LIG_SH3_3 | 139 | 145 | PF00018 | 0.618 |
LIG_TYR_ITSM | 69 | 76 | PF00017 | 0.452 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.723 |
MOD_GlcNHglycan | 5 | 8 | PF01048 | 0.831 |
MOD_GlcNHglycan | 52 | 55 | PF01048 | 0.536 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.790 |
MOD_GSK3_1 | 153 | 160 | PF00069 | 0.686 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.533 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.633 |
MOD_NEK2_1 | 42 | 47 | PF00069 | 0.557 |
MOD_NEK2_1 | 68 | 73 | PF00069 | 0.425 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.633 |
MOD_NEK2_2 | 14 | 19 | PF00069 | 0.492 |
MOD_NEK2_2 | 37 | 42 | PF00069 | 0.521 |
MOD_NEK2_2 | 91 | 96 | PF00069 | 0.727 |
MOD_PIKK_1 | 8 | 14 | PF00454 | 0.528 |
MOD_PKA_1 | 78 | 84 | PF00069 | 0.563 |
MOD_PKA_2 | 78 | 84 | PF00069 | 0.580 |
MOD_PKA_2 | 91 | 97 | PF00069 | 0.744 |
MOD_Plk_1 | 14 | 20 | PF00069 | 0.487 |
MOD_Plk_1 | 37 | 43 | PF00069 | 0.464 |
MOD_Plk_4 | 138 | 144 | PF00069 | 0.607 |
MOD_Plk_4 | 14 | 20 | PF00069 | 0.488 |
MOD_Plk_4 | 37 | 43 | PF00069 | 0.488 |
MOD_Plk_4 | 68 | 74 | PF00069 | 0.474 |
MOD_ProDKin_1 | 112 | 118 | PF00069 | 0.774 |
MOD_ProDKin_1 | 25 | 31 | PF00069 | 0.517 |
TRG_DiLeu_BaEn_2 | 37 | 43 | PF01217 | 0.576 |
TRG_ENDOCYTIC_2 | 161 | 164 | PF00928 | 0.634 |
TRG_ENDOCYTIC_2 | 73 | 76 | PF00928 | 0.530 |
TRG_ER_diArg_1 | 172 | 175 | PF00400 | 0.587 |
TRG_ER_diArg_1 | 76 | 79 | PF00400 | 0.704 |